May 03, 2015 at 16:56 | Source: PTI
Pilot also said that the action against Snapdeal and its top management was "akin to holding highway builders responsible for lane violations", while the real perpetrators are freely peddling drugs of dubious nature.
May 02, 2015 at 09:55 | Source: PTI
Maharashtra's Food and Drug Administration (FDA) clamped down on the e-commerce major for online sale of prescription drugs
May 01, 2015 at 15:58 | Source: PTI
Last month, FDA had raided the company's premises here in this regard. At that time, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.
Apr 28, 2015 at 10:19 | Source: Moneycontrol.com
Pharma major Wockhardt continued its downtrend on Tuesday as the company decided to recall its remaining batches of drugs from the US market, which was manufactured prior to the USFDA import alerts.
Apr 27, 2015 at 21:00 | Source: Moneycontrol.com
Kilitch Drugs India in its meeting held on April 27, 2015, has approved and consented to the terms of settlement arrived at with Aura Pharmaceuticals Inc. which inter alia spells out for payment of Rs. 15,00,000/- in full and final settlement and withdrawal and extinguishment of all claims of whatsoever nature made by Aura against the Company.
Apr 24, 2015 at 17:42 | Source: PTI
Mylan launches generic hepatitis C drug MCompany's Indian arm Mylan Pharmaceuticals has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the countryyHep in India
Apr 24, 2015 at 13:00 | Source: PTI
With these new patents, Suven has a total of 21 granted patents from Australia, 15 from Europe, 16 from Hong Kong, four from Israel and five from Norway. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.
Apr 22, 2015 at 22:27 | Source: CNBC-TV18
It is the first new TB drug to be launched in more than 40 years and one that offers a cure for drug-resistant strains of tuberculosis. The drug's innovator Janssen Pharma, will be launching the medicine only through the government's TB program, prompting medical practitioners to raise concern about its wider availability.
Apr 22, 2015 at 08:57 | Source: Moneycontrol.com
Natco is engaged in a legal battle to launch a generic version of Teva's top-selling drug Copaxone, patent on which expires in September.
Apr 21, 2015 at 13:41 | Source: Moneycontrol.com
Shares of Claris Lifesciences jumped more than 4 percent intraday on Tuesday on supplemental ANDA approval for antifungal medicine.